核心活检
医学
病理
活检
放射科
血液病理学
乳腺癌
内科学
生物
生物化学
癌症
细胞遗传学
染色体
基因
作者
Emad A. Rakha,Cecily Quinn,Wendy A. Raymond,Kimberly H. Allison,Sunil Badve,Edi Brogi,Grace Callagy,Emmanuelle Charafe‐Jauffret,Chih‐Jung Chen,Yunn‐Yi Chen,Laura C. Collins,Gábor Cserni,Lounes Djerroudi,Shabnam Jaffer,Maria Pia Foschini,Helenice Gobbi,Mihir Gudi,Oi Harada,Janina Kulka,Hajime Kuroda
标识
DOI:10.1016/j.modpat.2025.100734
摘要
Fibroepithelial lesions (FELs) of the breast constitute a heterogeneous group of biphasic tumours with variable morphology and behaviour. The classification of FELs is mainly based on a constellation of diagnostic criteria and intralesional heterogeneity is not uncommon. Therefore, reporting of FELs in a core needle biopsy (CNB) with limited tissue material can be challenging as not all the features may be represented for assessment. Distinction between classic fibroadenoma and representatively sampled phyllodes tumour is generally straightforward. However, cellular fibroadenoma, morphologically heterogeneous benign phyllodes tumour and myoid hamartoma can overlap histologically. Accurate grading of phyllodes tumour is also challenging on CNB and carries significant management implications. In this article, we provide an overview and propose a pragmatic approach to reporting FELs on CNB, particularly for lesions with overlapping features. Guidance using the UK/European 'B' classification of FELs, as well as free text descriptions of the various lesions, is also presented to help further management decision making.
科研通智能强力驱动
Strongly Powered by AbleSci AI